Dr Gillian Burgess, Site Head of UK Research and Vice President at Vertex Pharmaceuticals and Board Member of the Science Industry Partnership (SIP) of employers, sets out the business case for keeping up the momentum on diversity across the science industries.
Last week the government produced two reports looking at the vital statistics of the UK life sciences industry and the international competitiveness of the UK environment for life sciences businesses. Here we take a brief look at the data and pick out some interesting statistics.
Today the PM delivered a speech on the vital role AI can have in diagnosing chronic diseases and challenged the NHS, the AI sector and health charities to use data and AI to drastically improve current diagnosis capabilities to prevent 22,000 cancer deaths each year by 2033.
Genomic data is increasingly used in healthcare, yet the data’s European ancestry bias means that it is unrepresentative of the global population as a whole. In this blog, BIA member Global Gene Corp explores this issue and how the company is working to address the problem.
Over 300 Industry leaders from 160 leading organisations met in Cardiff last year at the 14th Annual bioProcessUK Conference. Top of the agenda, which focused on the latest news, updates and developments within the manufacturing and biologics arena, was the topic of skills, highlighted by many as one of the main drivers in building a stronger UK medicines manufacturing basis. In this blog, we take a look at some of the key points that were discussed.
Johnson and Johnson Innovation has recently launched a €100,000 funding competition aimed at supporting exciting innovative ideas, technologies and solutions from the European ecosystem for improving Human healthcare. In this blog, Christina McGrath, Innovation Activation QuickFire Challenge Manager at Johnson & Johnson Innovation, JLABS, explains the challenge’s background and what it aims to achieve.